Fed. Circ. Affirms Valeant Win In Antidepressant IP Battle

Law360, Washington (October 17, 2013, 6:36 PM ET) -- The Federal Circuit on Wednesday affirmed a Florida federal judge's victory for Valeant Pharmaceuticals International Inc. in its patent dispute with Watson Pharmaceuticals Inc. over the antidepressant Aplenzin, a decision preserving Valeant's exclusivity over the drug.

In a per curiam order, a three-judge panel affirmed a 2011 decision holding that Watson, now Actavis Inc., failed to prove Valeant's four patents covering the time-release antidepressant were invalid due to reasons of anticipation and obviousness.

Watson sought to market a generic equivalent of Valeant's version of the popular...
To view the full article, register now.